U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Pharmacoeconomic Review Report: Sucroferric Oxyhydroxide (Velphoro): (Vifor Fresenius Medical Care Renal Pharma Ltd.): Indication: For the control of serum phosphorus levels in adult patients with end-stage renal disease on dialysis [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Feb.

Cover of Pharmacoeconomic Review Report: Sucroferric Oxyhydroxide (Velphoro)

Pharmacoeconomic Review Report: Sucroferric Oxyhydroxide (Velphoro): (Vifor Fresenius Medical Care Renal Pharma Ltd.): Indication: For the control of serum phosphorus levels in adult patients with end-stage renal disease on dialysis [Internet].

Show details

Appendix 2Summary of Key Outcomes

The following summaries have been provided based on the CDR base case.

Table 7When Considering Only Costs, Outcomes and Quality of Life, How Attractive Is Sucroferric Oxyhydroxide vs. Sevelamer Hydrochloride?

Sucroferric Oxyhydroxide vs. SevelamerAttractiveSlightly AttractiveEqually AttractiveSlightly UnattractiveUnattractiveNA
Costs (total)X
Drug treatment costs aloneX
Clinical outcomesX
Quality of lifeX
Incremental CE ratio or net benefit calculationCDR base case: $2,870,896 per QALY

CDR = CADTH Common Drug Review; CE = cost-effectiveness; NA = not applicable.

Copyright © 2019 Canadian Agency for Drugs and Technologies in Health.

The copyright and other intellectual property rights in this document are owned by CADTH and its licensors. These rights are protected by the Canadian Copyright Act and other national and international laws and agreements. Users are permitted to make copies of this document for non-commercial purposes only, provided it is not modified when reproduced and appropriate credit is given to CADTH and its licensors.

Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/

Bookshelf ID: NBK542815
Contents

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (454K)

Other titles in this collection

Recent Activity

ClearTurn OffTurn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...